69198-10-3
69198-10-3 structure
- Name: metronidazole hydrochloride
- Chemical Name: metronidazole hydrochloride
- CAS Number: 69198-10-3
- Molecular Formula: C6H10ClN3O3
- Molecular Weight: 207.61500
- Catalog: Signaling Pathways Anti-infection Bacterial
- Create Date: 2016-02-04 12:48:42
- Modify Date: 2024-01-11 17:30:32
-
Metronidazole hydrochloride (SC 326421) is an orally active nitroimidazole antibiotic, can be used to research anaerobic infections. Metronidazole hydrochloride can cross blood brain barrier and results inflammation and skeletal muscle contraction under long-term application[1][2][3][4].
| Name | metronidazole hydrochloride |
|---|---|
| Synonyms |
Flagyl I.V.
2-Methyl-5-nitroimidazole-1-ethanol monohydrochloride 2-(2-methyl-5-nitroimidazol-1-yl)ethanol,hydrochloride 1H-Imidazole-1-ethanol,2-methyl-5-nitro-,hydrochloride 2-Methyl-5-nitroimidazole-1-ethanol hydrochloride Metronidazole Hcl Metronidazole hydrochloride |
| Description | Metronidazole hydrochloride (SC 326421) is an orally active nitroimidazole antibiotic, can be used to research anaerobic infections. Metronidazole hydrochloride can cross blood brain barrier and results inflammation and skeletal muscle contraction under long-term application[1][2][3][4]. |
|---|---|
| Related Catalog | |
| In Vitro | Metronidazole hydrochloride acts on anaerobic microorganism following: passage through the cell membrane; (b) reductive action; (c) interaction with intracellular targets; (d) release of inactive end products, exerts function with toxic nitro and nitroso derivatives[1]. Metronidazole hydrochloride displays inhibitory activity towards anaerobic protozoa Trichomonas vaginalis, Entamoeba histolytica, Giardia lamblia, and Balantidium coli[1]. Metronidazole hydrochloride (4-8 μg/mL) inhibits anaerobic bacteria and shows good bactericidal activity[1]. Metronidazole hydrochloride (0.1 μg/mL-0.01 mg/mL; 12-96 h) induces granular formation and triggers apoptosis in Blastocystis sp[2]. Apoptosis Analysis[2] Cell Line: Blastocystis sp. Cells Concentration: 0.1 μg/mL-0.01 mg/mL Incubation Time: 12, 24, 48, 60, 72, 84, 96 hours Result: Decreased cell diameter, as a hallmark of an apoptotic cell, and resulted cell shrinkage. |
| In Vivo | Metronidazole hydrochloride (135 mg/kg/d; p.o.; 28 d) can cross the blood brain barrier, and exhibits neurotoxicity under long term administration in rats[3]. Metronidazole hydrochloride (1 g/L; p.o.; 4 weeks) results skeletal muscle atrophy and changes the expression of genes involved in the muscle peripheral circadian rhythm machinery and metabolic regulation[4]. Animal Model: Sprague-Dawley (SD) rats (200-220 g)[3] Dosage: 135 mg/kg Administration: Oral gavage; once daily; 28 days Result: Caused inflammatory markers increasing, including iNOS, eNOS, Bax and caspase 3 protein expressions increasing and caused oxidative stress damage in brain tissue, with MDA content rising. Animal Model: SPF C57Bl/6J mice (6-7 months old)[4] Dosage: 1 g/L (full dose) Administration: Oral gavage; provided with drinking water for 4 weeks, changed twice weekly Result: Resulted the muscle core clock and effector genes Cry2, Ror-β, E4BP4, PP ARγ and adiponectin expression increasing. Decreased hind limb muscle weight and resulted in smaller fibers in the tibialis anterior muscle. |
| References |
[1]. Scully BE. Metronidazole. Med Clin North Am. 1988 May;72(3):613-21. |
| Boiling Point | 405.4ºC at 760 mmHg |
|---|---|
| Melting Point | 158-160ºC |
| Molecular Formula | C6H10ClN3O3 |
| Molecular Weight | 207.61500 |
| Flash Point | 199ºC |
| Exact Mass | 207.04100 |
| PSA | 83.87000 |
| LogP | 1.41720 |